BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kubota J, Ikeda F, Terada R, Kobashi H, Fujioka S, Okamoto R, Baba S, Morimoto Y, Ando M, Makino Y, Taniguchi H, Yasunaka T, Miyake Y, Iwasaki Y, Yamamoto K. Mortality rate of patients with asymptomatic primary biliary cirrhosis diagnosed at age 55 years or older is similar to that of the general population. J Gastroenterol 2009;44:1000-6. [PMID: 19562250 DOI: 10.1007/s00535-009-0090-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ikeda F, Okamoto R, Baba N, Fujioka S, Shoji B, Yabushita K, Ando M, Matsumura S, Kubota J, Yasunaka T. Prevalence and associated factors with esophageal varices in early primary biliary cirrhosis. J Gastroenterol Hepatol. 2012;27:1320-1328. [PMID: 22414162 DOI: 10.1111/j.1440-1746.2012.07114.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
2 Trivedi PJ, Corpechot C, Pares A, Hirschfield GM. Risk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists. Hepatology. 2016;63:644-659. [PMID: 26290473 DOI: 10.1002/hep.28128] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
3 Cheung AC, Lammers WJ, Murillo Perez CF, van Buuren HR, Gulamhusein A, Trivedi PJ, Lazaridis KN, Ponsioen CY, Floreani A, Hirschfield GM, Corpechot C, Mayo MJ, Invernizzi P, Battezzati PM, Parés A, Nevens F, Thorburn D, Mason AL, Carbone M, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lindor KD, Lleo A, Poupon R, Janssen HL, Hansen BE; Global PBC Study Group. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis. Clin Gastroenterol Hepatol. 2019;. [PMID: 30616022 DOI: 10.1016/j.cgh.2018.12.028] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
4 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017;67:145-172. [PMID: 28427765 DOI: 10.1016/j.jhep.2017.03.022] [Cited by in Crossref: 409] [Cited by in F6Publishing: 326] [Article Influence: 81.8] [Reference Citation Analysis]
5 Floreani A, Spinazzè A, Caballeria L, Reig A, Cazzagon N, Franceschet I, Buja A, Furlan P, Harada K, Leung PS, Gershwin ME, Pares A. Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers. Clin Rev Allergy Immunol 2015;48:254-62. [PMID: 25205363 DOI: 10.1007/s12016-014-8446-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
6 Janmohamed A, Trivedi PJ. Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC). Best Pract Res Clin Gastroenterol 2018;34-35:71-83. [PMID: 30343713 DOI: 10.1016/j.bpg.2018.06.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shoji B, Ikeda F, Fujioka S, Kobashi H, Yasunaka T, Miyake Y, Shiraha H, Takaki A, Nouso K, Iwasaki Y, Yamamoto K. Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis B virus-related liver disease. J Gastroenterol 2010;45:1172-82. [DOI: 10.1007/s00535-010-0266-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Untas A, Boujut E, Corpechot C, Zenasni F, Chazouillères O, Jaury P, Poupon R, Buffel du Vaure C, Sultan S. Quality of life and illness perception in primary biliary cirrhosis: A controlled cross-sectional study. Clinics and Research in Hepatology and Gastroenterology 2015;39:52-8. [DOI: 10.1016/j.clinre.2014.07.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
9 Seki A, Ikeda F, Miyatake H, Takaguchi K, Hayashi S, Osawa T, Fujioka S, Tanaka R, Ando M, Seki H, Iwasaki Y, Yamamoto K, Okada H. Risk of secondary osteoporosis due to lobular cholestasis in non-cirrhotic primary biliary cholangitis: Osteoporosis in non-cirrhotic PBC. Journal of Gastroenterology and Hepatology 2017;32:1611-6. [DOI: 10.1111/jgh.13746] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
10 You H, Ma X, Efe C, Wang G, Jeong SH, Abe K, Duan W, Chen S, Kong Y, Zhang D, Wei L, Wang FS, Lin HC, Yang JM, Tanwandee T, Gani RA, Payawal DA, Sharma BC, Hou J, Yokosuka O, Dokmeci AK, Crawford D, Kao JH, Piratvisuth T, Suh DJ, Lesmana LA, Sollano J, Lau G, Sarin SK, Omata M, Tanaka A, Jia J. APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis. Hepatol Int 2022. [PMID: 35119627 DOI: 10.1007/s12072-021-10276-6] [Reference Citation Analysis]